PPM1D and lymphoma: The potential value of inhibiting Wip1 in moderating cancer progression is not only limited to Tax–induced tumors because a Wip1 effect has also been suggested in mammary gland tumors [95], lymphomas [96], colorectal cancers [97], and other spontaneous tumors [98].